Changzhou Qianhong Biopharma Co Ltd Sustainability Reports

Changzhou Qianhong Biopharma Co., Ltd. researches, develops, manufactures, and sells biopharmaceutical products in China and internationally. The company primary specializes in polysaccharide and protease drugs, including heparin sodium, heparin calcium, enoxaparin sodium, pancreatin, and asparaginase.

Sector: Manufacturing

Country: China

Exchange: Shenzhen Stock Exchange

FIGI: BBG001TG4TW7

1 reports from 2023 to 2023

• Changzhou Qianhong Biopharma Co Ltd 2023 Environmental, Social and Governance (ESG) Report